NCT01311999

Completed

Surveillance and Follow-up for Latent Tuberculosis Infection...

National Taiwan University Hospital Source

Compare

Other study identifiers

Sponsor study identifier

201009057R

Study Type

observational

Actual enrollment (reported)

234

Locations

1 country

Sites

1

Timeline

Study Start

February 2011

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

November 2013

Actual (reported)

Study Completion

November 2013

Actual (reported)

Brief Summary

To follow-up the latent tuberculosis infection and the risk of developing active tuberculosis in patients receiving long-term dialysis

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 234 participants
Study completion date: November 2013
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2011
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
March 8, 2011
Actual (reported)
First Posted
March 10, 2011
Actual (reported)
Primary Completion
November 2013
Actual (reported)
Study Completion
November 2013
Actual (reported)

Last Updated: December 4, 2013
Status Verified: December 2013
Last Update Submitted: December 3, 2013

Conditions

To Predict the Potential of Development of Active Tuberculosis in Those Receiving Long-term Dialysis by Using Interferon-gamma Release Assy

Keywords

latent tuberculosis, renal failure, dialysis, interferon-gamma release assay

Outcome Measures

Primary Outcomes (1)

Development of active tuberculosis
3 years

Study Arms (2)

IGRA-positive group

The subjects who have positive results of interferon-gamma release assay

IGRA-negative group

The subjects who have negative results of interferon-gamma release assay

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

The patients receiving long-term dialysis

You may qualify if:

age equal to or more than 18-years old

Sponsors & Collaborators

National Taiwan University Hospital
Otherlead

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

MeSH Terms

Conditions

Latent TuberculosisRenal Insufficiency

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent InfectionKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

Chin-Chung Shu, MD
National Taiwan University Hospital
PRINCIPAL INVESTIGATOR

Enrollment

234 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 8, 2011

First Posted

March 10, 2011

Study Start

February 2011

Date type not reported

This date has not been verified as actual or estimated.

having received dialysis more than 3 months

You may not qualify if:

Positive HIV test
Liver cirrhosis, Child-Pugh class C
Receiving long-term systemic corticosteroid use
Receiving chemotherapy within recent three months
Life span is less than one year
Being suspected to have active tuberculosis

Contact the study team to confirm eligibility.

Male Urogenital Diseases

Primary Completion

November 2013

Actual (reported)

Study Completion

November 2013

Actual (reported)

Last Updated

December 4, 2013

Record last verified: 2013-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01311999
Data provider: ClinicalTrials.gov
Source updated: 2013-12-04
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:51 UTC

Locations

TW(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

IGRA-positive group

IGRA-negative group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations